This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Wang, Guangdi
| Item Type | Name |
|
Academic Article
|
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
|
|
Academic Article
|
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).
|
|
Academic Article
|
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
|
|
Academic Article
|
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models.
|
|
Academic Article
|
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.
|
|
Concept
|
Estrogen Antagonists
|
|
Concept
|
Estrogens
|
|
Concept
|
Receptors, Estrogen
|
|
Concept
|
Selective Estrogen Receptor Modulators
|
|
Concept
|
Estrogen Receptor alpha
|
|
Academic Article
|
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
|
|
Academic Article
|
Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.
|
|
Academic Article
|
GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer.
|
|
Academic Article
|
Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer.
|
|
Academic Article
|
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
|
|
Academic Article
|
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target.
|
|
Academic Article
|
Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents.
|
|
Academic Article
|
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD).
|